Surprise! PDUFA Fees Dropping In FY 2021
A more than 2% drop for NDAs and BLAs in FY 2021, while program fees will increase more than 3%.
You may also be interested in...
The US FDA fee for a new drug or biologics license application requiring clinical data will jump to $2.94m in October.
ACIP defers vote on who should be inoculated first until it has data on a specific product, but vaccine acceptance among different groups could be weighed as factor in setting distribution priorities, committee members suggest.
The possibility, which seems driven by the culture of the times, may be legally possible, but experts raised many practical concerns.